Glucocorticoids and invasive fungal infections.

By M. Lionakis, D. Kontoyiannis. The Lancet, 2003

629 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Aspergillus Infections in Transplant Recipients (2005, background): “Defects in phagocytic function, neutropenia, and corticosteroid therapy have long been recognized as significant risk factors for invasive aspergillosis (55, 169, 274).”
Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. (2005, background): “Functional impairment of neutrophils in the setting of hyperglycemia identifies a subgroup of patients at high risk for opportunistic mold infections [30].”